🇺🇸 FDA
Pipeline program

Treatment Algorithm A

RP1706

Approved mab active

Quick answer

Treatment Algorithm A for Colitis, Ulcerative is a Approved program (mab) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Colitis, Ulcerative
Phase
Approved
Modality
mab
Status
active

Clinical trials